The absence of ADAMTS13 improves early outcomes in an experimental model of trauma with uncontrolled hemorrhage
Pieter H. Sloos, Lisa Vermeersch, Rizwan Hameed, M. Adrie W. Maas, Anne-Sophie Delmote, Joris J.T.H. Roelofs, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld · 2026
Read The absence of ADAMTS13 improves early outcomes in an experimental model of trauma with uncontrolled hemorrhage by Pieter H. Sloos, Lisa Vermeersch, Rizwan Hameed, M. Adrie W. Maas, Anne-Sophie Delmote, Joris J.T.H. Roelofs, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619138.txt.
Description
Pieter Sloos and co-authors test whether the absence of the enzyme ADAMTS13 improves early outcomes after trauma with uncontrolled bleeding. Their 2026 experimental study uses mice, and also checks a common anti-bleeding drug.
Trauma bleeding is worsened by a clotting disorder that follows injury. In shocked trauma patients, levels of this enzyme fall while its activity can rise, which may aggravate bleeding. Wild-type and knockout mice were injured and bled without control. A separate experiment tested tranexamic acid, which blocks plasmin, for its effect on the enzyme. The question is whether removing this enzyme protects the injured body, a possible new treatment angle.
Catalog record
| CREATOR | Pieter H. Sloos, Lisa Vermeersch, Rizwan Hameed, M. Adrie W. Maas, Anne-Sophie Delmote, Joris J.T.H. Roelofs, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |